Opdivo useless in high PD1 NSCLC pats! Merck takes clear lead! Bloodbath coming... huge layoff announcement before the end of the year....sell off of CV franchise.
Lol why the hell would they sell off CV when it's the only thing they have going after this oncology disaster
Bristol is now on life support, they are in desperate need of cash to pay the dividend and continue enormously expensive clinical trials of Opdivo. Why do you think they have been slowly selling off pieces of the company? Management is trying to avoid a death spiral scenario in which the company goes up for sale.
enjoying the stock tanking. Ex oncology employee that left due to poor management and nightmare pod structure
